Dr. Mussawar Iqbal MD

Consultant Medical Oncologist and Assistant professor University of Saskatchewan.

I did my initial education and medical training in Pakistan, completed higher medical and Medical Oncology training in UK – completing in December 2002. I have been working as Consultant Medical oncologist since then. From 1^st of September 2014, I have joined Allan Blair Cancer center - Regina. I am providing general oncology services, with sub-specialty interest of GI, Lung, Brain, Skin and Neuroendocrine oncology.  I have been actively involved in Medical student training and teaching, during their rotation to at Allan Blair Cancer center.

• A. Bashir1, M. Iqbal2, A.M. Abdel-Hamid1, To assess impact of revised FIGO staging on survival of patients with uterine leiomyosarcoma – Single centre experience. The International Journal of Gynecological Cancer – October 2012, vol 22, issue 8, supplement 3
• The perceived value of avoiding biopsy: patien willingness to pay for circulating tumour DNA EGFR T790M – poster presentation – World Lung cancer 2017.
• Real-world study of Osimertinib in EGFR T790M-mutated non-small cell lung cancer (NSCLC): ASTRIS Canadian cohort analysis – Poster presentation - World Lung Cancer 2018.
• Multicenter validation study to implement plasma EGFR T790 testing in clinical laboratories. JCO precision Oncology 4:520-533, 15 May 2020.